albendazole has been researched along with Graft vs Host Disease in 1 studies
Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sutrave, G | 1 |
| Maundrell, A | 1 |
| Keighley, C | 1 |
| Jennings, Z | 1 |
| Brammah, S | 1 |
| Wang, MX | 1 |
| Pamphlett, R | 1 |
| Webb, CE | 1 |
| Stark, D | 1 |
| Englert, H | 1 |
| Gottlieb, D | 1 |
| Bilmon, I | 1 |
| Watts, MR | 1 |
1 other study available for albendazole and Graft vs Host Disease
| Article | Year |
|---|---|
Anncaliia algerae Microsporidial Myositis, New South Wales, Australia.
Topics: Aged; Albendazole; Antiprotozoal Agents; Graft vs Host Disease; Hematopoietic Stem Cell Transplantat | 2018 |